IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma

Cell Death and Differentiation

Volumn 7, Issue 7, 2000, Pages 654-665

  Van Golen, C M ^a   Castle, V P ^a   Feldman, E L ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Caspase; IGF IR; Mannitol; Mitochondria; SHEP

Indexed keywords

CASPASE 3; PROTEIN BCL 2; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033937809     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400693     Document Type: Article

References (94)

1. Castleberry RP (1997) Biology and treatment of neuroblastoma. Pediatr. Clin. North. Am. 44: 919-936
2. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD and White PS (1997) Biology and genetics of human neuroblastomas. J. Pediatr. Hematol. Oncol. 19: 93-101
3. Cianfarani S and Rossi P (1997) Neuroblastoma and insulin-like growth factor system - New insights and clinical perspectives. Eur. J. Pediatr. 156: 256-261
4. Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su M, Zhao H, Cnaan A and Sakiyama S (1997) High levels of expression and nuclear localization of interleukin-1 B converting enzyme (ICE) and CPP32 in favorable human neuroblastoma. Cancer Res. 57: 4578-4584
5. Gelbard HA, Boustany RM and Schor NF (1997) Apoptosis in development and disease of the nervous system. 2. Apoptosis in childhood neurologic disease. Pediatr. Neurol. 16: 93-97
6. Jones JI and Clemmons DR (1995) Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 16: 3-34
7. Rubin R and Baserga R (1995) Insulin-like growth factor-I receptor - Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Invest. 73: 311-331
8. Li S, Ferger A, Miura M and Baserga R (1994) Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain. J. Biol. Chem. 269: 32558-32564
9. Hongo A, D'Ambrosio C, Miura M, Morrione A and Baserga R (1996) Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor. Oncogene 12: 1231-1238
10. Surmacz E, Sell C, Swantek J, Kato H, Roberts CJ, LeRoith D and Baserga R (1995) Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor. Exp. Cell. Res. 218: 370-380
11. Li SW, Resnicoff M and Baserga R (1996) Effect of mutations at serines 1280-1283 on the mitogenic and transforming activities of the insulin-like growth factor I receptor. J. Biol. Chem. 271: 12254-12260.
12. Miura M, Surmacz E, Burgaud J-L and Baserga R (1995) D fferent effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J. Biol. Chem. 270: 22639-22644
13. Singleton JR, Randolph AE and Feldman EL (1996) Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res. 56: 4522-4529
14. Kim B, Cheng H-L, Margolis B and Feldman EL (1998) Insulin receptor substrate-2 and Shc play different roles in insulin-like growth factor-I signaling. J. Biol. Chem. 273: 34543-34550
15. White M and Kahn CR (1994) The insulin signaling system. J Biol. Chem. 269: 1-4
16. Sun JS, Rothenburg P, Kahn CR, Backer JM, Aracki E, Wilden PA, Cahill DA, Oldstein BJ and White MF (1991) Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352: 73-77
17. Liu Q, Schacher D, Hurth C, Freund GG, Dantzer R and Kelley KW (1997) Activation of phosphatidylinositol 3′-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes. J. Immunol. 159: 829-837
18. Minshall C, Arkins S, Freund GG and Kelley KW (1996) Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156: 939-947
19. D'Mello SR, Borodezt K and Soltoff SP (1997) Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: Possible involvement of PI 3-kinase in IGF-1 signaling. J. Neurosci. 17: 1548-1560
20. Miller TM, Tansey MG, Johnson Jr EM and Creedon DJ (1997) Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells. J. Biol. Chem. 272: 9847-9853
21. Kulik G, Klippel A and Weber MJ (1997) Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17: 1595-1606
22. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR and Greenberg ME (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665
23. Reed JC (1994) Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124: 1-6
24. Jacobson MD and Evan GI (1994) Breaking the ice. Structural and functional similarities have been discovered between two mammalian proteins, Bcl-2 and interleukin 1 β-converting enzyme, and proteins encoded by nematode cell-death genes. Curr. Biol. 4: 337-340
25. Schendel SL, Xie Z, Montal MO, Matsuyama S, Montal M and Reed JC (1997) Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA 94: 5113-5118
26. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT and Thompson CB (1997) Bcl-xl regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627-637
27. L forms an ion channel in synthetic lipid membranes. Nature 385: 353-357
28. Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C and Pleasure D (1991) Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 51: 6529-6538
29. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res. 55: 2576-2582
30. Singleton JR, Dixit VM and Feldman EL (1996) Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271: 31791-31794
31. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW and Yuan J (1996) Human ICE/CED-3 protease nomenclature. Cell 87: 171
32. Villa P, Kaufmann SH, Earnshaw WC (1997) Caspases and caspase inhibitors. Trends Biochem. Sci. 22: 388-393
33. Tewari M and Dixit VM (1995) Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270: 3255-3260
34. Chinnaiyan AM, O'Rourke K, Tewari M and Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512
35. Tewari M, Beidler DR and Dixit VM (1995) CrmA-inhibitable cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein during fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270: 18738-18741
36. Janicke RU, Sprengart ML, Wati MR and Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273: 9357-9360
37. Woo M, Hakem R, Soengas MS, Duncan GS, Shahinian A, Kagi D, Hakem A, McCurrach M, Khoo W, Kaufman SA, Senaldi G, Howard T, Lowe SW and Mak TW (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12: 806-819
38. van Golen CM and Feldman EL (2000) Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis. J. Cell Physiol. 182: 24-32
39. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA and Castle VP (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54: 3253-3259
40. Leventhal PS, Randolph AE, Vesbit TE, Schenone A, Windebank AJ and Feldman EL (1995) Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. Exp. Cell. Res. 221: 179-186
41. Biedler JL, Spengler BA, Tien-ding C and Ross RA (1988) Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Adv. Neuroblastoma Res. 2: 265-276
42. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776
43. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Remy R, Xie ZH, Reed JC and Kroemer G (1998) The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 187: 1261-1271
44. Kroemer G, Dallaporta B and Resche-Rigon M (1998) The mitochondrial death/ life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60: 619-642
45. Macaulay VM (1992) Insulin-like growth factors and cancer. Br. J. Cancer 65: 311-320
46. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL and Cuttitta F (1996) Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem. 271: 11477-11483
47. Matthews CC, Odeh H and Feldman EL (1997) Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience 79: 525-534
48. Werner H and Le Roith D (1997) The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit. Rev. Oncog. 8: 71-92
49. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P and Baserga R (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55: 2463-2469
50. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R and Rubin R (1994) Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res. 54: 2218-2222
51. Ambrose D, Resnicoff M, Coppola D, Sell C, Miura M, Jameson S, Baserga R and Rubin R (1994) Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. J. Cell Physiol. 159: 92-100
52. Prager D, Li H-L, Asa S and Melmed S (1994) Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. USA 91: 2181-2185
53. Kaleko M, Rutter WJ and Miller AD (1900) Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol. 10: 464-473
54. Sell C, Baserga R and Rubin R (1995) Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55: 303-306
55. Baserga R (1994) Oncogenes and the strategy of growth factors. Cell 79: 927-930
56. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P and Flavell RA (1998) Reduced apoptosis and cytochrome-c mediated caspase activation in mice lacking caspase 9. Cell 94: 325-337
57. Kim B, Leventhal PS and Feldman EL (1996) Insulin-like growth factor-I (IGF-I) induces localization of RAC and phosphatidylinositol 3-kinase (PI3-K) to membrane ruffles. Mol. Biol. Cell. 7: 342a (Abstract)
58. Dunn SE, Hardman RA, Kari FW and Barrett JC (1997) Insulin-like growth factor I (IGF-I) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res. 57: 2687-2693
59. Guo YS, Jin GF, Houston CW, Thompson JC and Townsend Jr CM (1998) Insulin-like growth factor-I promotes multidrug resistance in MCLM colon cancer cells. J. Cell Physiol. 175: 141-148
60. Lamm GM and Christofori G (1998) Impairment of survival factor function potentiates chemotherapy-induced apoptosis in tumor cells. Cancer Res. 58: 801-807
61. Skaper SD, Floreani M, Negro A, Facci L and Giusti P (1998) Neurotrophins rescue cerebellar granule neurons from oxidative stress-mediated apoptotic death: selective involvement of phosphatidylinositol 3-kinase and the mitogen-activated protein kinase pathway. J. Neurochem. 70: 1859-1868
62. Eldadah BA, Yakovlev AG and Faden AI (1997) The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule cells. J. Neurosci. 17: 6105-6113
63. Rivera S, Guillot S, Agassandian C, Ben Ari Y and Khrestchatisky M (1998) Serum deprivation-induced apoptosis in cultured hippocampi is prevented by kainate. Neuroreport 9: 3949-3953
64. Yano S, Tokumitsu H and Soderling TR (1998) Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396: 584-587
65. Solovyan V, Bezvenyuk Z, Huotari V, Tapiola T, Suuronen T and Salminen A (1998) Distinct mode of apoptosis induced by genotoxic agent etoposide and serum withdrawal in neuroblastoma cells. Brain Res. Mol. Brain Res. 62: 43-55
66. Bozzo C, Bellomo G, Silengo L, Tarone G and Altruda F (1997) Soluble integrin ligands and growth factors independently rescue neuroblastoma cells from apoptosis under nonadherent conditions. Exp. Cell. Res. 237: 326-337
67. Wang L, Ma W, Markovich R, Lee WL and Wang PH (1998) Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 139: 1354-1360
68. Parrizas M, Saltiel AR and LeRoith D (1997) Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J. Biol. Chem. 272: 154-161
69. Russell JW, Windebank AJ, Schenone A and Feldman EL (1998) Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J. Neurobiol. 36: 455-467
70. Posmantur R, McGinnis K, Nadimpalli R, Gilbertsen RB and Wang KKW (1997) Characterization of CPP32-like protease activity following apoptotic challenge in SH-SY5Y neuroblastoma cells. J. Neurochem. 68: 2328-2337
71. Uehara T, Kikuchi Y and Nomura Y (1999) Caspase activation accompanying cytochrome C release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SH-SY5Y cells. J. Neurochem. 72: 196-205
72. Nath R, Probert Jr A, McGinnis KM and Wang KK (1998) Evidence for activation of caspase-3-like protease in excitotoxin- and hypoxia/hypoglycemia-injured neurons. J. Neurochem. 71: 186-195
73. Werner H (1998) Dysregulation of the type 1 IGF receptor as a paradigm in tumor progression. Mol. Cell. Endocrinol. 141: 1-5
74. Resnik JL, Reichart DB, Huey K, Webster NJ and Seely BL (1998) Elevated insulin-like growth factor I receptor autophosphorylation and kinase activity in human breast cancer. Cancer Res. 58: 1159-1164
75. Liu X, Turbyville T, Fritz A and Whitesell L (1998) Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in mice. Cancer Res. 58: 5432-5438
76. Boyle CC and Hickman JA (1997) Toxin-induced increase in survival factor receptors: modulation of the threshold for apoptosis. Cancer Res. 57: 2404-2409
77. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R and Anversa P (1997) Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100: 1991-1999
78. Guvakova MA and Surmacz E (1997) Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Exp. Cell. Res. 231: 149-162
79. Reed JC, Miyashita T, Takayama S, Wang H-G, Sato T, Krajewski S, Aime-Sempe C, Bodrog S, Kitada S and Hanada M (1996) Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biol. 60: 23-32
80. Merry DE and Korsmeyer SJ (1997) Bcl-2 gene family in the nervous system. Annu. Rev. Neurosci. 20: 245-267
81. Srinivasan A, Foster LM, Testa MP, Ord T, Keane RW, Bredesen DE and Kayalar C (1996) Bcl-2 expression in neural cells blocks activation of ICE/CED-3 family proteases during apoptosis. J. Neurosci. 16: 5654-5660
82. Bonnotte B, Favre N, Moutet M, Fromentin A, Solary E, Martin M and Martin F (1998) Bcl-2-mediated inhibition of apoptosis prevents imrnunogenicity and restores tumorigenicity of spontaneously regressive tumors. J. Immunol 161: 1433-1438
83. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136
84. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP and Wang X (1997) Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
85. Fulda S, Susin SA, Kroemer G and Debatin K-M (1998) Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells. Cancer Res. 58: 4453-4460
86. Samali A, Cai J, Zhivotovsky B, Jones DP and Orrenius S (1999) Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J. 18: 2040-2048
87. Bossy-Wetzel E, Newmeyer DD and Green DR (1998) Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarizat on. EMBO J. 17: 37-49
88. McGinnis KM, Gnegy ME and Wang KK (1999) Endogenous bax translocalion in SH-SY5Y human neuroblastoma cells and cerebellar granule neurons undergoing apoptosis. J. Neurochem. 72: 1899-1906
89. Eskes R, Antonsson B, Osen-Sand A, Montessuit S, Richter C, Sadoul R, Mazzei G, Nichols A and Martinou JC (1998) Bax-induced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell. Biol. 143: 217-224
90. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D and Reed JC (1998) Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95: 4997-5002
91. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis [see comments]. Science 275: 1132-1136
92. Cosulich SC, Savory PJ and Clarke PR (1999) Bcl-2 regulates amplification of caspase activation by cytochrome c. Curr. Biol. 9: 147-150
93. del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689
94. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241